Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The Use of Recombinant Poliovirus for the Treatment of Recurrent Glioblastoma Multiforme.

Abi-Aad KR, Turcotte EL, Welz ME, Krishna C, Mrugala MM, Porter AB, Vora SA, Bendok BR.

World Neurosurg. 2019 Jan 22. pii: S1878-8750(19)30147-0. doi: 10.1016/j.wneu.2019.01.050. [Epub ahead of print] No abstract available.

PMID:
30682513
2.

Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.

Ochiai H, Campbell SA, Archer GE, Chewning TA, Dragunsky E, Ivanov A, Gromeier M, Sampson JH.

Clin Cancer Res. 2006 Feb 15;12(4):1349-54.

3.

Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.

Goetz C, Gromeier M.

Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):197-203. doi: 10.1016/j.cytogfr.2010.02.005. Epub 2010 Mar 17. Review.

4.

Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.

Dobrikova EY, Broadt T, Poiley-Nelson J, Yang X, Soman G, Giardina S, Harris R, Gromeier M.

Mol Ther. 2008 Nov;16(11):1865-72. doi: 10.1038/mt.2008.184. Epub 2008 Sep 2.

5.

Glioblastoma multiforme: the terminator.

Holland EC.

Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6242-4. No abstract available.

6.

p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme.

Stark AM, Witzel P, Strege RJ, Hugo HH, Mehdorn HM.

J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):779-83.

7.

Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma.

Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC, Lai A, Nghiemphu PL, Mason WP, Cloughesy TF.

AJNR Am J Neuroradiol. 2014 Apr;35(4):673-9. doi: 10.3174/ajnr.A3748. Epub 2013 Oct 17.

8.

Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy.

Archavlis E, Tselis N, Birn G, Ulrich P, Zamboglou N.

Neurol Res. 2014 Dec;36(12):1047-55. doi: 10.1179/1743132814Y.0000000398. Epub 2014 May 23.

PMID:
24852696
9.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
10.

Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.

Simpson L, Galanis E.

Expert Rev Anticancer Ther. 2006 Nov;6(11):1593-607. Review.

PMID:
17134364
11.

Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus.

Brown MC, Gromeier M.

Curr Opin Virol. 2015 Aug;13:81-5. doi: 10.1016/j.coviro.2015.05.007. Epub 2015 Jun 12. Review.

12.

Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression.

Ghulam Muhammad AK, Candolfi M, King GD, Yagiz K, Foulad D, Mineharu Y, Kroeger KM, Treuer KA, Nichols WS, Sanderson NS, Yang J, Khayznikov M, Van Rooijen N, Lowenstein PR, Castro MG.

Clin Cancer Res. 2009 Oct 1;15(19):6113-27. doi: 10.1158/1078-0432.CCR-09-1087. Epub 2009 Sep 29.

13.

Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.

Batash R, Asna N, Schaffer P, Francis N, Schaffer M.

Curr Med Chem. 2017;24(27):3002-3009. doi: 10.2174/0929867324666170516123206. Review.

PMID:
28521700
14.

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.

Li R, Chen X, You Y, Wang X, Liu Y, Hu Q, Yan W.

Oncotarget. 2015 Oct 13;6(31):30968-74. doi: 10.18632/oncotarget.5038.

15.

Reoxygenation of hypoxic glioblastoma multiforme cells potentiates the killing effect of an interleukin-13-based cytotoxin.

Liu TF, Cai J, Gibo DM, Debinski W.

Clin Cancer Res. 2009 Jan 1;15(1):160-8. doi: 10.1158/1078-0432.CCR-08-2151.

16.

Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme.

Combs SE, Gutwein S, Thilmann Ch, Huber P, Debus J, Schulz-Ertner D.

J Neurooncol. 2005 Sep;74(2):167-71.

PMID:
16193388
17.

[Treatment of recurrent glioblastoma with single-agent bevacizumab].

Sinkó D, Nemeskéri C.

Orv Hetil. 2016 Mar 27;157(13):500-3. doi: 10.1556/650.2015.30395. Hungarian.

PMID:
26996897
18.

Glioblastoma multiforme with bone metastase and cauda equina syndrome.

Lampl Y, Eshel Y, Gilad R, Sarova-Pinchas I.

J Neurooncol. 1990 Apr;8(2):167-72.

PMID:
2162916
19.

'Recurrent' glioblastoma multiforme, when should we reoperate?

Barbagallo GM, Jenkinson MD, Brodbelt AR.

Br J Neurosurg. 2008 Jun;22(3):452-5. doi: 10.1080/02688690802182256. Review.

PMID:
18568742
20.

Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.

Burzynski SR, Lewy RI, Weaver R, Janicki T, Jurida G, Khan M, Larisma CB, Paszkowiak J, Szymkowski B.

Integr Cancer Ther. 2004 Sep;3(3):257-61.

PMID:
15312271

Supplemental Content

Support Center